Changes in Physical Functioning in Patients With COPD During Therapy With a Combination Inhalation Therapy

NCT02173769 · clinicaltrials.gov ↗

COMPLETED

Status

1845

Enrollment

INDUSTRY

Sponsor class

Conditions

Pulmonary Disease, Chronic Obstructive

Interventions

DRUG: Spiriva® Respimat®
DRUG: Striverdi® Respimat®

Sponsor

Boehringer Ingelheim